Research graph
References from Exploring the link between asprosin and glucose and lipid dysregulation in offspring of diabetic mothers in a rat model. Local targets link to admitted publications; unresolved targets remain external evidence.
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2024
2024 · External reference
Diabetes and stroke: what are the connections?
10.5853/jos.2022.02306 · 2023 · External reference
Diabetic peripheral neuropathy: pathogenetic mechanisms and treatment
10.3389/fendo.2023.1265372 · 2024 · External reference
Association between diabetes, diabetic retinopathy, and glaucoma
10.1007/s11892-021-01404-5 · 2021 · External reference
Complications of diabetes 2017
10.1155/2018/3086167 · 2018 · External reference
Epidemiological factors for type 2 diabetes mellitus: evidence from the Global Burden of Disease
10.1186/s13690-021-00632-1 · 2021 · External reference
International diabetes federation
2015 · External reference
Mechanisms of early life programming: current knowledge and future directions
2011 · External reference
Early-life programming of type 2 diabetes mellitus: understanding the association between epigenetics/genetics and environmental factors
10.2174/1389202920666191009110724 · 2019 · External reference
Early-life origins of type 2 diabetes: fetal programming of the beta-cell mass
10.1155/2011/105076 · 2011 · External reference
Early-life nutritional programming of type 2 diabetes: experimental and quasi-experimental evidence
10.3390/nu9030236 · 2017 · External reference
Obesity and metabolic abnormalities in offspring of subjects with diabetes mellitus
10.1089/dia.2009.0163 · 2010 · External reference
The cross-link between adipokines, insulin resistance and obesity in offspring of diabetic pregnancies
10.1159/000448076 · 2016 · External reference
Intergenerational cycle of obesity and diabetes: how can we reduce the burdens of these conditions on the health of future generations?
2011 · External reference
Asprosin in umbilical cord of newborns and maternal blood of gestational diabetes, preeclampsia, severe preeclampsia, intrauterine growth retardation and macrosemic fetus
10.1016/j.peptides.2019.170132 · 2019 · External reference
Leptin concentrations in cord blood in normal newborn infants and offspring of diabetic mothers
10.1055/s-2007-978776 · 1999 · External reference
Cord blood leptin levels in gestational diabetes
2010 · External reference
Increased maternal and cord blood betatrophin in gestational diabetes
10.1371/journal.pone.0131171 · 2015 · External reference
Association of parental obesity and diabetes mellitus with circulating adipokines in nonobese nondiabetic offspring
10.1161/jaha.116.004973 · 2017 · External reference
Adipokines in human milk and risk of overweight in early childhood: a prospective cohort study
10.1097/ede.0b013e3181567ed4 · 2007 · External reference
Impact of the adipokine adiponectin and the hepatokine fetuin-A on the development of type 2 diabetes: prospective cohort- and cross-sectional phenotyping studies
10.1371/journal.pone.0092238 · 2014 · External reference
Asprosin, a fasting-induced glucogenic protein hormone
10.1016/j.cell.2016.02.063 · 2016 · External reference
Maternal exposure to air pollution and umbilical asprosin concentration, a novel insulin-resistant marker
10.1016/j.chemosphere.2020.129228 · 2021 · External reference
Plasma asprosin concentrations are increased in individuals with glucose dysregulation and correlated with insulin resistance and first-phase insulin secretion
10.1155/2018/9471583 · 2018 · External reference
Serum concentration of asprosin in new-onset type 2 diabetes
10.1186/s13098-020-00564-w · 2020 · External reference
Asprosin attenuates insulin signaling pathway through PKCδ-activated ER stress and inflammation in skeletal muscle
10.1002/jcp.28694 · 2019 · External reference
Epigenetic changes and alteration of Fbn1 and Col3A1 gene expression under hyperglycaemic and hyperinsulinaemic conditions
10.1042/bj20100414 · 2010 · External reference
Circulating asprosin concentrations are increased in type 2 diabetes mellitus and independently associated with fasting glucose and triglyceride
10.1016/j.cca.2017.10.034 · 2019 · External reference
Association between plasma asprosin levels and gestational diabetes mellitus
10.2147/dmso.s424651 · 2023 · External reference
Continuous elevation of plasma asprosin in pregnant women complicated with gestational diabetes mellitus: a nested case-control study
10.1016/j.placenta.2020.02.004 · 2020 · External reference
Circulating asprosin levels in type 2 diabetes mellitus: a systematic review and meta-analysis
10.1016/j.cegh.2023.101502 · 2024 · External reference
Asprosin serum levels and glucose homeostasis in children with obesity
10.1016/j.cyto.2021.155477 · 2021 · External reference
Increased serum circulating asprosin levels in children with obesity
10.1111/ped.14176 · 2020 · External reference
Decreased circulating levels of asprosin in obese children
10.1159/000500523 · 2019 · External reference
Serum asprosin concentrations are increased and associated with insulin resistance in children with obesity
10.1159/000503808 · 2019 · External reference
The use of animal models in diabetes research
10.1111/j.1476-5381.2012.01911.x · 2012 · External reference
Animal models of diabetes mellitus
10.1111/j.1464-5491.2005.01499.x · 2005 · External reference
Guidelines for the design and statistical analysis of experiments using laboratory animals
10.1093/ilar.43.4.244 · 2002 · External reference
Asprosin attenuates insulin signaling pathway through PKCδ-activated ER stress and inflammation in skeletal muscle
10.1002/jcp.28694 · ExternalCitation · doi-reference
Association between diabetes, diabetic retinopathy, and glaucoma
10.1007/s11892-021-01404-5 · ExternalCitation · doi-reference
Circulating asprosin concentrations are increased in type 2 diabetes mellitus and independently associated with fasting glucose and triglyceride
10.1016/j.cca.2017.10.034 · ExternalCitation · doi-reference
Circulating asprosin levels in type 2 diabetes mellitus: a systematic review and meta-analysis
10.1016/j.cegh.2023.101502 · ExternalCitation · doi-reference
Asprosin, a fasting-induced glucogenic protein hormone
10.1016/j.cell.2016.02.063 · ExternalCitation · doi-reference
Maternal exposure to air pollution and umbilical asprosin concentration, a novel insulin-resistant marker
10.1016/j.chemosphere.2020.129228 · ExternalCitation · doi-reference
Asprosin serum levels and glucose homeostasis in children with obesity
10.1016/j.cyto.2021.155477 · ExternalCitation · doi-reference
Asprosin in umbilical cord of newborns and maternal blood of gestational diabetes, preeclampsia, severe preeclampsia, intrauterine growth retardation and macrosemic fetus
10.1016/j.peptides.2019.170132 · ExternalCitation · doi-reference
Continuous elevation of plasma asprosin in pregnant women complicated with gestational diabetes mellitus: a nested case-control study
10.1016/j.placenta.2020.02.004 · ExternalCitation · doi-reference
Epigenetic changes and alteration of Fbn1 and Col3A1 gene expression under hyperglycaemic and hyperinsulinaemic conditions
10.1042/bj20100414 · ExternalCitation · doi-reference
Leptin concentrations in cord blood in normal newborn infants and offspring of diabetic mothers
10.1055/s-2007-978776 · ExternalCitation · doi-reference
Obesity and metabolic abnormalities in offspring of subjects with diabetes mellitus
10.1089/dia.2009.0163 · ExternalCitation · doi-reference
Guidelines for the design and statistical analysis of experiments using laboratory animals
10.1093/ilar.43.4.244 · ExternalCitation · doi-reference
Adipokines in human milk and risk of overweight in early childhood: a prospective cohort study
10.1097/ede.0b013e3181567ed4 · ExternalCitation · doi-reference
Animal models of diabetes mellitus
10.1111/j.1464-5491.2005.01499.x · ExternalCitation · doi-reference
The use of animal models in diabetes research
10.1111/j.1476-5381.2012.01911.x · ExternalCitation · doi-reference
Increased serum circulating asprosin levels in children with obesity
10.1111/ped.14176 · ExternalCitation · doi-reference
Early-life origins of type 2 diabetes: fetal programming of the beta-cell mass
10.1155/2011/105076 · ExternalCitation · doi-reference
Complications of diabetes 2017
10.1155/2018/3086167 · ExternalCitation · doi-reference
Plasma asprosin concentrations are increased in individuals with glucose dysregulation and correlated with insulin resistance and first-phase insulin secretion
10.1155/2018/9471583 · ExternalCitation · doi-reference
The cross-link between adipokines, insulin resistance and obesity in offspring of diabetic pregnancies
10.1159/000448076 · ExternalCitation · doi-reference
Decreased circulating levels of asprosin in obese children
10.1159/000500523 · ExternalCitation · doi-reference
Serum asprosin concentrations are increased and associated with insulin resistance in children with obesity
10.1159/000503808 · ExternalCitation · doi-reference
Association of parental obesity and diabetes mellitus with circulating adipokines in nonobese nondiabetic offspring
10.1161/jaha.116.004973 · ExternalCitation · doi-reference
Serum concentration of asprosin in new-onset type 2 diabetes
10.1186/s13098-020-00564-w · ExternalCitation · doi-reference
Epidemiological factors for type 2 diabetes mellitus: evidence from the Global Burden of Disease
10.1186/s13690-021-00632-1 · ExternalCitation · doi-reference
Impact of the adipokine adiponectin and the hepatokine fetuin-A on the development of type 2 diabetes: prospective cohort- and cross-sectional phenotyping studies
10.1371/journal.pone.0092238 · ExternalCitation · doi-reference
Increased maternal and cord blood betatrophin in gestational diabetes
10.1371/journal.pone.0131171 · ExternalCitation · doi-reference
Association between plasma asprosin levels and gestational diabetes mellitus
10.2147/dmso.s424651 · ExternalCitation · doi-reference
Early-life programming of type 2 diabetes mellitus: understanding the association between epigenetics/genetics and environmental factors
10.2174/1389202920666191009110724 · ExternalCitation · doi-reference
Diabetic peripheral neuropathy: pathogenetic mechanisms and treatment
10.3389/fendo.2023.1265372 · ExternalCitation · doi-reference
Early-life nutritional programming of type 2 diabetes: experimental and quasi-experimental evidence
10.3390/nu9030236 · ExternalCitation · doi-reference
Diabetes and stroke: what are the connections?
10.5853/jos.2022.02306 · ExternalCitation · doi-reference
